Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
- Research Partnership’s MedTech Division appoints two Directors
- Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
- Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
- Putting behavioural science at the forefront of market research
Research Partnership
- Quantitative specialist joins Research Partnership, London
- Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London
Research Partnership
- Webcast
- Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights
Research Partnership
- Webcast
- The power of a good story: Turn your insights into effective storytelling with data visualisation
Research Partnership
